1. Market Research
  2. > Therapy
29 reports for Salicylic Acid (page 1)

Purchase Reports From Reputable Market Research Publishers

Age-Related Macular Degeneration: Global Drug Forecast and Market Analysis to 2028

  • $ 10995
  • April 2020
  • 204 pages

ONE OF THESE STUDIES INVESTIGATES THE EFFICACY, COST-EFFECTIVENESS, AND SAFETY OF ASPIRIN FOR THE MANAGEMENT OF ALL FORMS OF LATE AMD.

  • Ophthalmology
  • Salicylic Acid
  • Targeted Therapy
  • Therapy
  • Australia

Pain Medication OTC Manufacturing in Australia - Industry Market Research Report

  • $ 640
  • February 2020
  • 34 pages

Declining popularity is also due to salicylate intolerances, suggested links between aspirin and gastrointestinal bleeding.

  • Analgesic
  • OTC
  • Pain Relief
  • Salicylic Acid
  • Australia

Pharmaceutical Product Manufacturing in Australia - Industry Market Research Report

  • $ 710
  • March 2020
  • 44 pages

Other products include non-prescription analgesics such as paracetamol and aspirin, cough and cold remedies, and anti-fungal treatments.

  • Pharmaceutical
  • Salicylic Acid
  • Australia
  • Pfizer Inc.
  • Sanofi S.A.

Pet Healthcare in Australia

  • $ 350
  • December 2018
  • 37 pages

These products are offered under known brands such as Claritin, Aspirin, Aleve, Bepanthen/ Bepanthol, Canesten, Dr.

  • Healthcare
  • Salicylic Acid
  • Australia
  • Bayer AG
  • Virbac SA

Seed Production in Australia - Industry Market Research Report

  • $ 905
  • June 2019
  • 35 pages

Bayer' s position in the global seeds market has grown the creator of aspirin.

  • Agricultural Products
  • Salicylic Acid
  • Australia
  • Demand

Cosmetics, Perfume and Toiletries Manufacturing in Australia - Industry Market Research Report

  • $ 710
  • March 2020
  • 42 pages

Custom-compounding of plastic resins includes custom mixing and blending of purchased plastic resins and reformulating plastic resins from Industry products include active ingredients such as benzoyl peroxide, salicylic acid, sulfur, resorcinol or a This industry manufactures over-the-count

  • Cosmetics
  • Fragrance
  • Salicylic Acid
  • Australia
  • Demand

Analgesics in Australia

  • $ 990
  • October 2019
  • 22 pages

Cartia is the leading brand in aspirin, while Dymadon presents strong competition in acetaminophen, where it is among the leading names.

  • Analgesic
  • OTC
  • Salicylic Acid
  • Australia
  • Demand

Paediatric Consumer Health in Australia

  • $ 990
  • October 2019
  • 22 pages

aspirin are increasingly offered as paediatric variants under private label.

  • OTC
  • Salicylic Acid
  • Australia
  • Demand

Consumer Health in Australia

  • $ 2650
  • October 2019
  • 102 pages

Cartia is the leading brand in aspirin, while Dymadon presents strong competition in acetaminophen, where it is among the leading names.

  • OTC
  • Salicylic Acid
  • Australia
  • Demand
  • Sanofi S.A.

Online Pharmaceutical Sales in Australia - Industry Market Research Report

  • $ 905
  • August 2018
  • 32 pages

J## Internet Service Providers in Australia PRODUCTS & SERVICES Online pharmacies have a varied product portfolio, including products such as aspirin, anti-inflammatories, antihistamines and sun-care products, alongside cosmetics, personal care items and baby-care products, with some

  • Pharmaceutical
  • Pharmacy
  • Salicylic Acid
  • Australia
  • Demand

OTC Pharmaceuticals in Australia

  • $ 350
  • September 2016
  • 39 pages

Aspirin and other analgesics), medicated skin products (anti-bacterials, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/ gels), plasters & bandages (adhesive bandages/ plasters, first aid

  • Pharmaceutical
  • Salicylic Acid
  • Australia
  • GlaxoSmithKline plc
  • Pfizer Inc.

IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Australia

  • $ 1870
  • June 2017
  • 55 pages

This includes analgesics such as aspirin and paracetamol (in small pack sizes), as well as antihistamines, cough and cold remedies and topical antifungals.

  • Health Services
  • Hospital
  • Pharmaceutical
  • Salicylic Acid
  • Australia

Monash University - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • December 2018
  • 56 pages

Significant bleeding-a known risk of regular aspirin use-was also measured.

  • Healthcare
  • Pharmaceutical
  • Salicylic Acid
  • Therapy
  • Australia

Australia Nephrology and Urology Devices Market Outlook to 2025 - Renal Dialysis Equipment

  • $ 5995
  • April 2020
  • 68 pages

MVP expects About Penthrox Penthrox is a fast onset, non-opioid analgesic indicated for pain relief by self-administration in patients with trauma and those requiring analgesia for surgical procedures.

  • Dialysis Device
  • Urology Device
  • Australasia
  • Australia
  • Simavita Limited

Aspen Pharmacare Holdings Ltd (APN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • December 2018
  • 79 pages

Cartia Aspirin ( GlaxoSmithKline Australia Pty Ltd - Marketed ) Dequadin OTC Brands Zantac GlobalData PARTNERSHIPS Aspen Pharmacare Holdings to Enter into Research Agreement with Far Eastern Federal University Aspen Pharmacare Holdings to Enter into Research Agreement with Far Eastern Feder

  • Healthcare
  • Pharmaceutical
  • Salicylic Acid
  • Australia
  • Aspen Pharmacare Holdings Limited

Aspen Pharmacare Australia Pty Ltd in Consumer Health (Australia)

  • $ 428
  • June 2015
  • 2 pages

aspirin, combination products, antihistamines, paediatric cough/ cold remedies, antacids, H## blockers and antiparasitics.

  • Gastrointestinal Drug
  • OTC
  • Salicylic Acid
  • Australia
  • Aspen Pharmacare Holdings Limited

CSL Ltd (CSL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • November 2018
  • 95 pages

aspirin ( Novartis AG - Marketed ) Cell-Derived H##N##sw Monovalent Vaccine ( Novartis AG - PipeLine ) Cibalginafor ( Novartis AG - Marketed ) diclofenac potassium ( Novartis AG - Marketed ) diclofenac sodium ( Novartis AG - Marketed ) Flucelvax ( Novartis AG - Marketed ) Target Asset Informa

  • Pharmaceutical
  • Salicylic Acid
  • Vaccine
  • Australia
  • CSL Limited

Kaposi Sarcoma - Pipeline Review, H1 2020

  • $ 2000
  • March 2020
  • 294 pages

All patients received thromboprophylaxis with low-dose aspirin, low-molecular-weight heparin, or equivalent.

  • Chemotherapy
  • Hospital
  • Salicylic Acid
  • Therapy
  • Australia

University of New South Wales - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • September 2018
  • 41 pages

Other trials will explore the effectiveness and safety of aspirin compared to heparin to treat blood clots and test a new triple therapy regimen to target rare viral-driven brain lymphomas.

  • Healthcare
  • Psychotic Disorder
  • Salicylic Acid
  • Therapy
  • Australia

The University of New South Wales - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • June 2018
  • 29 pages

Other trials will explore the effectiveness and safety of aspirin compared to heparin to treat blood clots and test a new triple therapy regimen to target rare viral-driven brain lymphomas.

  • Healthcare
  • Psychotic Disorder
  • Salicylic Acid
  • Therapy
  • Australia
View report >

OTC Markets

  • January 2019
  • 70 pages

Summary of APSMI Country Report 2019 INTRODUCTION....................................................................................... ## I.

  • OTC
  • Salicylic Acid
  • Australia
  • Japan
  • Demand

Opioid Market January 2019

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on